Clinical Trial Update: Immune Signature Analysis of Disease Progression in Post Immunotherapy Lung Cancer Patients

View source ↗

Summary

This clinical trial update describes analysis of immune signatures associated with disease progression in patients with non-small cell lung cancer who have prev…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: Wake Forest University Health Sciences | Conditions: Lung Cancer, Nonsmall Cell | Status: ACTIVE_NOT_RECRUITING